Abstract:Major Depressive Disorder (MDD) represents a significant societal burden, with traditional first-line treatments often falling short. This pressing issue has spurred the exploration of neuromodulation therapies, demonstrating superior efficacy compared to conventional pharmaceutical interventions. The present review provides a rigorous evaluation of four advanced neuromodulation techniques: Focal Electrically Administered Seizure Therapy (FEAST), Transcranial Magnetic Stimulation (TMS), Intermittent Theta-Burst Stimulation (iTBS), and Magnetic Seizure Therapy (MST). A comprehensive analytical comparison is offered, focusing on their efficacy, feasibility, economic considerations, and underlying mechanisms. Among these therapies, iTBS, integrated with Brain-Computer Interface (BCI) systems, has emerged as notably effective, with clinical trials indicating an average 80% efficacy at a reduced economic cost. FEAST and MST, supported by recent research, also exhibit strong efficacy, around 60%, although with more pronounced side effects. TMS, in contrast, exhibits a slightly reduced efficacy but is promising due to its minimal side effects. The review further delves into the transformative role of increasingly sophisticated BCI technologies in addressing previously identified challenges of neuromodulation therapy, such as adverse side effects, time-consuming procedures, and high costs. These technological advancements are elucidated, emphasizing their contribution to more precise therapy delivery and an enhanced patient experience. The review culminates in illuminating a pathway for the harmonious integration of neuromodulation therapies with traditional psychopharmacological treatments, positioning this integrative approach as a groundbreaking paradigm poised to redefine the landscape of depression treatment.

Therapeutic Potential and Mechanisms of Stem Cells in Major Depressive Disorder: a Comprehensive Review

Plausible Role of Stem Cell Types for Treating and Understanding the Pathophysiology of Depression

The roles of extracellular vesicles in major depressive disorder

The therapeutic potential of traditional Chinese medicine in depression: focused on the modulation of neuroplasticity

Mesenchymal Stem Cells Improve Depressive Disorder via Inhibiting the Inflammatory Polarization of Microglia

Research Progress on Mechanisms of Modulating Gut Microbiota to Improve Symptoms of Major Depressive Disorder

Brain-Computer Interface Based Neuromodulation on Treatment of Depression

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications

The molecular mechanism of polysaccharides in combating major depressive disorder: A comprehensive review

Advances in Optogenetic Studies of Depressive-Like Behaviors and Underlying Neural Circuit Mechanisms

A Review of Research on the Association between Neuron-Astrocyte Signaling Processes and Depressive Symptoms

Mechanisms Supporting Potential Use of Bone Marrow-Derived Mesenchymal Stem Cells in Psychocardiology.

Pathogenesis of depression and the potential for traditional Chinese medicine treatment

Potential Anti-Depressive Treatment Maneuvers from Bench to Bedside.

Mechanisms Of Repetitive Transcranial Magnetic Stimulation For Anti-Depression: Evidence From Preclinical Studies

Adult hippocampal neurogenesis: pharmacological mechanisms of antidepressant active ingredients in traditional Chinese medicine

Effects of Electroconvulsive Therapy on Depression and Its Potential Mechanism

Neurotrophic basis to the pathogenesis of depression and phytotherapy

Brain structural and functional changes in patients with major depressive disorder: a literature review

Prevention and treatment of natural products from Traditional Chinese Medicine in depression: Potential targets and mechanisms of action

Exploring the transformative impact of traditional Chinese medicine on depression: Insights from animal models